• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Medtronic (NY: MDT )

    87.72 -0.40 (-0.45%)
    Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Medtronic

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    46 47 Next >
    Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
    Medtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance. 
    Via MarketBeat
    Exposures Product Safety
    Medtronic Analysts Boost Their Forecasts After Upbeat Earnings
    Via Benzinga
    Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Medtronic (MDT) Q1 2025 Earnings Call Transcript
    MDT earnings call for the period ending June 30, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
    It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices traded in the red at around midday trading in New York. 
    Via Benzinga
    Key Takeaways From Medtronic Analyst Ratings
    Via Benzinga
    Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
    Via Benzinga
    MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q1 2025
    MDT stock results show that Medtronic beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
    Via InvestorPlace
    Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches
    Medtronic beats Q1 2025 earnings and revenue estimates with $7.9 billion in sales, driven by growth in Cardiac, Neuromodulation, and Diabetes segments. The company raises FY25 guidance, citing strong... 
    Via Benzinga
    Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter
    Medtronic stock rose early Tuesday after the medtech company reported slightly better-than-expected results for its fiscal first quarter. 
    Via Investor's Business Daily
    US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
    The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Looking Into Medtronic's Recent Short Interest
    Via Benzinga
    Why NYSE:MDT qualifies as a good dividend investing stock.
    Balancing Dividends and Fundamentals: The Case of MEDTRONIC PLC (NYSE:MDT). 
    Via Chartmill
    S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    5 Dividend Growth Stocks to Buy and Hold Forever
    Dividend growth stocks offer investors a powerful combination of income and capital appreciation potential, making them attractive for long-term portfolios. 
    Via The Motley Fool
    3 Dividend Stocks to Double Up On Right Now
    How does a 5.7% dividend yield sound? 
    Via The Motley Fool
    Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    7 Defensive Stocks to Buy as Investors Seek Shelter
    With the market primed for more jitters, investors should consider battening down the hatches with these defensive stocks. 
    Via InvestorPlace
    TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
    Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
    Via MarketBeat
    Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
    An unexpected diabetes partnership with Medtronic bodes well for Abbott's biggest growth driver. 
    Via The Motley Fool
    Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
    From Orchestra BioMed Holdings, Inc.
    Via GlobeNewswire
    Chips, Glorious Chips!
    Someone's gotta make 'em, and someone's gotta buy 'em. 
    Via The Motley Fool
    Medical Technology Stock Benefits from Rising Acute Care Demand
    Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
    Via MarketBeat
    Topics Supply Chain
    Exposures Supply Chain
    Why Intuitive Surgical Stock is Dominating the Medical Sector
    Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
    Via MarketBeat
    2 Dividend Stocks to Buy and Never Sell
    These two are rock-solid businesses with strong dividend programs. 
    Via The Motley Fool
    As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
    Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
    Via Investor's Business Daily
    3 AI-Powered Healthcare Stocks Transforming Medicine
    Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    3 AI-in-Healthcare Stocks to Buy for Outsized Returns
    These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    46 47 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.